Dengue Virus Nonstructural Protein 1 Induces Vascular Leakage through Macrophage Migration Inhibitory Factor and Autophagy

PLoS Neglected Tropical Diseases

Volumn 10, Issue 7, 2016, Pages

  Chen, Hong Ru ^a   Chuang, Yung Chun ^a   Lin, Yee Shin ^a   Liu, Hsiao Sheng ^a   Liu, Ching Chuan ^a,b   Perng, Guey Chuen ^a   Yeh, Trai Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; NONSTRUCTURAL PROTEIN 1; PROTEIN ZO1; RECOMBINANT PROTEIN; VASCULAR ENDOTHELIAL CADHERIN; VIRUS ANTIBODY; VIRAL PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; AUTOPHAGY; BLOOD VESSEL PERMEABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PROTEIN PURIFICATION; VASCULAR DISEASE; VASCULAR LEAKAGE; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CAPILLARY PERMEABILITY; CELL LINE; METABOLISM; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ANTIBODIES, VIRAL; AUTOPHAGY; CAPILLARY PERMEABILITY; CELL LINE; DENGUE VIRUS; ENDOTHELIUM, VASCULAR; HUMANS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; MICE, INBRED BALB C; VIRAL NONSTRUCTURAL PROTEINS;

EID: 84980410226     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004828     Document Type: Article

References (68)

1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496(7446):504–7. Epub 2013/04/09. doi: 10.1038/nature1206023563266; PubMed Central PMCID: PMCPmc3651993.
2. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ, et al. Dengue: a continuing global threat. Nat Rev Microbiol. 2010;8(12 Suppl):S7–16. Epub 2010/11/17. doi: 10.1038/nrmicro246021079655; PubMed Central PMCID: PMCPmc4333201.
3. Narvaez F, Gutierrez G, Perez MA, Elizondo D, Nunez A, Balmaseda A, et al. Evaluation of the traditional and revised WHO classifications of Dengue disease severity. PLoS Negl Trop Dis. 2011;5(11):e1397. doi: 10.1371/journal.pntd.000139722087348; PubMed Central PMCID: PMC3210746.
4. Martina BE, Koraka P, Osterhaus AD, Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev. 2009;22(4):564–81. Epub 2009/10/14. doi: 10.1128/cmr.00035-0919822889; PubMed Central PMCID: PMCPmc2772360.
5. Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, Wongtapradit L, Nithipanya N, Kalayanarooj S, et al. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J. 2007;26(4):283–90. Epub 2007/04/07. doi: 10.1097/01.inf.0000258612.26743.1017414388.
6. Guzman MG, Harris E, Dengue. Lancet. 2015;385(9966):453–65. Epub 2014/09/19. doi: 10.1016/s0140-6736(14)60572-925230594.
7. Gutsche I, Coulibaly F, Voss JE, Salmon J, d'Alayer J, Ermonval M, et al. Secreted dengue virus nonstructural protein NS1 is an atypical barrel-shaped high-density lipoprotein. Proc Natl Acad Sci U S A. 2011;108(19):8003–8. Epub 2011/04/27. doi: 10.1073/pnas.101733810821518917; PubMed Central PMCID: PMCPmc3093454.
8. Edeling MA, Diamond MS, Fremont DH, Structural basis of Flavivirus NS1 assembly and antibody recognition. Proc Natl Acad Sci U S A. 2014;111(11):4285–90. Epub 2014/03/07. doi: 10.1073/pnas.132203611124594604; PubMed Central PMCID: PMCPmc3964132.
9. Akey DL, Brown WC, Dutta S, Konwerski J, Jose J, Jurkiw TJ, et al. Flavivirus NS1 structures reveal surfaces for associations with membranes and the immune system. Science. 2014;343(6173):881–5. Epub 2014/02/08. doi: 10.1126/science.124774924505133; PubMed Central PMCID: PMCPmc4263348.
10. Alcon S, Talarmin A, Debruyne M, Falconar A, Deubel V, Flamand M, Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol. 2002;40(2):376–81. Epub 2002/02/05. 11825945; PubMed Central PMCID: PMCPmc153354.
11. Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S, et al. High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever. J Infect Dis. 2002;186(8):1165–8. Epub 2002/10/02. doi: 10.1086/34381312355369.
12. Young PR, Hilditch PA, Bletchly C, Halloran W, An antigen capture enzyme-linked immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected patients. J Clin Microbiol. 2000;38(3):1053–7. Epub 2000/03/04. 10698995; PubMed Central PMCID: PMCPmc86336.
13. Avirutnan P, Zhang L, Punyadee N, Manuyakorn A, Puttikhunt C, Kasinrerk W, et al. Secreted NS1 of dengue virus attaches to the surface of cells via interactions with heparan sulfate and chondroitin sulfate E. PLoSPathog. 2007;3(11):e183. Epub 2007/12/07. doi: 10.1371/journal.ppat.003018318052531; PubMed Central PMCID: PMCPmc2092380.
14. Lin SW, Chuang YC, Lin YS, Lei HY, Liu HS, Yeh TM, Dengue virus nonstructural protein NS1 binds to prothrombin/thrombin and inhibits prothrombin activation. J Infect. 2012;64(3):325–34. Epub 2011/12/06. doi: 10.1016/j.jinf.2011.11.02322138554.
15. Avirutnan P, Punyadee N, Noisakran S, Komoltri C, Thiemmeca S, Auethavornanan K, et al. Vascular leakage in severe dengue virus infections: a potential role for the nonstructural viral protein NS1 and complement. J Infect Dis. 2006;193(8):1078–88. Epub 2006/03/18. doi: 10.1086/50094916544248.
16. Avirutnan P, Fuchs A, Hauhart RE, Somnuke P, Youn S, Diamond MS, et al. Antagonism of the complement component C4 by flavivirus nonstructural protein NS1. J Exp Med. 2010;207(4):793–806. Epub 2010/03/24. doi: 10.1084/jem.2009254520308361; PubMed Central PMCID: PMCPmc2856034.
17. Avirutnan P, Hauhart RE, Somnuke P, Blom AM, Diamond MS, Atkinson JP, Binding of flavivirus nonstructural protein NS1 to C4b binding protein modulates complement activation. J Immunol. 2011;187(1):424–33. Epub 2011/06/07. doi: 10.4049/jimmunol.110075021642539; PubMed Central PMCID: PMCPmc3119735.
18. Modhiran N, Watterson D, Muller DA, Panetta AK, Sester DP, Liu L, et al. Dengue virus NS1 protein activates cells via Toll-like receptor 4 and disrupts endothelial cell monolayer integrity. Sci Transl Med. 2015;7(304):304ra142. Epub 2015/09/12. doi: 10.1126/scitranslmed.aaa386326355031.
19. Beatty PR, Puerta-Guardo H, Killingbeck SS, Glasner DR, Hopkins K, Harris E, Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination. Sci Transl Med. 2015;7(304):304ra141. Epub 2015/09/12. doi: 10.1126/scitranslmed.aaa378726355030.
20. Bazzoni G, Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost. 2006;95(1):36–42. 16543959.
21. Komarova Y, Malik AB, Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol. 2010;72:463–93. doi: 10.1146/annurev-physiol-021909-13583320148685.
22. Peters K, Unger RE, Brunner J, Kirkpatrick CJ, Molecular basis of endothelial dysfunction in sepsis. Cardiovasc Res. 2003;60(1):49–57. Epub 2003/10/03. 14522406.
23. Forster C, Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol. 2008;130(1):55–70. Epub 2008/04/17. doi: 10.1007/s00418-008-0424-918415116; PubMed Central PMCID: PMCPmc2413111.
24. Srikiatkhachorn A, Plasma leakage in dengue haemorrhagic fever. Thromb Haemost. 2009;102(6):1042–9. Epub 2009/12/08. doi: 10.1160/th09-03-020819967133.
25. Lei HY, Yeh TM, Liu HS, Lin YS, Chen SH, Liu CC, Immunopathogenesis of dengue virus infection. J Biomed Sci. 2001;8(5):377–88. Epub 2001/09/11. 54058. 11549879.
26. Luplertlop N, Misse D, Bray D, Deleuze V, Gonzalez JP, Leardkamolkarn V, et al. Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep. 2006;7(11):1176–81. Epub 2006/10/10. doi: 10.1038/sj.embor.740081417028575; PubMed Central PMCID: PMCPmc1679776.
27. St John AL, Rathore AP, Raghavan B, Ng ML, Abraham SN, Contributions of mast cells and vasoactive products, leukotrienes and chymase, to dengue virus-induced vascular leakage. Elife. 2013;2:e00481. Epub 2013/05/03. doi: 10.7554/eLife.0048123638300; PubMed Central PMCID: PMCPmc3639510.
28. Chuang YC, Lei HY, Liu HS, Lin YS, Fu TF, Yeh TM, Macrophage migration inhibitory factor induced by dengue virus infection increases vascular permeability. Cytokine. 2011;54(2):222–31. Epub 2011/02/16. doi: 10.1016/j.cyto.2011.01.01321320786.
29. Chen HR, Chuang YC, Chao CH, Yeh TM, Macrophage migration inhibitory factor induces vascular leakage via autophagy. Biol Open. 2015;4(2):244–52. Epub 2015/01/27. doi: 10.1242/bio.20141032225617421.
30. Chuang YC, Chen HR, Yeh TM, Pathogenic roles of macrophage migration inhibitory factor during dengue virus infection. Mediators Inflamm. 2015;2015:547094. Epub 2015/03/31. doi: 10.1155/2015/54709425821355; PubMed Central PMCID: PMCPmc4363636.
31. Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13(5):587–96. Epub 2007/04/17. doi: 10.1038/nm156717435771.
32. Schwartz V, Lue H, Kraemer S, Korbiel J, Krohn R, Ohl K, et al. A functional heteromeric MIF receptor formed by CD74 and CXCR4. FEBS Lett. 2009;583(17):2749–57. Epub 2009/08/12. doi: 10.1016/j.febslet.2009.07.05819665027; PubMed Central PMCID: PMCPmc2911026.
33. Lue H, Kapurniotu A, Fingerle-Rowson G, Roger T, Leng L, Thiele M, et al. Rapid and transient activation of the ERK MAPK signalling pathway by macrophage migration inhibitory factor (MIF) and dependence on JAB1/CSN5 and Src kinase activity. Cell Signal. 2006;18(5):688–703. Epub 2005/08/27. doi: 10.1016/j.cellsig.2005.06.01316122907.
34. Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, et al. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity. Oncogene. 2007;26(35):5046–59. Epub 2007/02/22. doi: 10.1038/sj.onc.121031817310986.
35. Calandra T, Bernhagen J, Mitchell RA, Bucala R, The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994;179(6):1895–902. Epub 1994/06/01. 8195715; PubMed Central PMCID: PMCPmc2191507.
36. Kudchodkar SB, Levine B, Viruses and autophagy. Rev Med Virol. 2009;19(6):359–78. Epub 2009/09/15. doi: 10.1002/rmv.63019750559; PubMed Central PMCID: PMCPmc2852112.
37. Joven J, Guirro M, Marine-Casado R, Rodriguez-Gallego E, Menendez JA, Autophagy is an inflammation-related defensive mechanism against disease. Adv Exp Med Biol. 2014;824:43–59. doi: 10.1007/978-3-319-07320-0_625038993.
38. Choi AM, Ryter SW, Levine B, Autophagy in human health and disease. N Engl J Med. 2013;368(19):1845–6. doi: 10.1056/NEJMc130315823656658.
39. Eskelinen EL, New insights into the mechanisms of macroautophagy in mammalian cells. Int Rev Cell Mol Biol. 2008;266:207–47. Epub 2008/06/12. doi: 10.1016/S1937-6448(07)66005-518544495.
40. Mizushima N, Methods for monitoring autophagy. Int J Biochem Cell Biol. 2004;36(12):2491–502. doi: 10.1016/j.biocel.2004.02.00515325587.
41. Hansen TE, Johansen T, Following autophagy step by step. BMC Biol. 2011;9:39. doi: 10.1186/1741-7007-9-3921635796; PubMed Central PMCID: PMC3107173.
42. Lee YR, Lei HY, Liu MT, Wang JR, Chen SH, Jiang-Shieh YF, et al. Autophagic machinery activated by dengue virus enhances virus replication. Virology. 2008;374(2):240–8. Epub 2008/03/21. doi: 10.1016/j.virol.2008.02.01618353420.
43. Liu IJ, Chiu CY, Chen YC, Wu HC, Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus. J Biol Chem. 2011;286(11):9726–36. Epub 2011/01/15. doi: 10.1074/jbc.M110.17099321233208; PubMed Central PMCID: PMCPmc3058979.
44. Chen CL, Lin CF, Wan SW, Wei LS, Chen MC, Yeh TM, et al. Anti-dengue virus nonstructural protein 1 antibodies cause NO-mediated endothelial cell apoptosis via ceramide-regulated glycogen synthase kinase-3beta and NF-kappaB activation. J Immunol. 2013;191(4):1744–52. Epub 2013/07/16. doi: 10.4049/jimmunol.120197623851680.
45. Sun DS, King CC, Huang HS, Shih YL, Lee CC, Tsai WJ, et al. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J Thromb Haemost. 2007;5(11):2291–9. Epub 2007/10/26. doi: 10.1111/j.1538-7836.2007.02754.x17958746.
46. Chuang YC, Lin YS, Liu HS, Wang JR, Yeh TM, Antibodies against thrombin in dengue patients contain both anti-thrombotic and pro-fibrinolytic activities. Thromb Haemost. 2013;110(2):358–65. Epub 2013/06/07. doi: 10.1160/th13-02-014923740201.
47. Assuncao-Miranda I, Amaral FA, Bozza FA, Fagundes CT, Sousa LP, Souza DG, et al. Contribution of macrophage migration inhibitory factor to the pathogenesis of dengue virus infection. FASEB J. 2010;24(1):218–28. Epub 2009/09/25. doi: 10.1096/fj.09-13946919776337.
48. Al-Abed Y, Dabideen D, Aljabari B, Valster A, Messmer D, Ochani M, et al. ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem. 2005;280(44):36541–4. Epub 2005/08/24. doi: 10.1074/jbc.C50024320016115897.
49. Calandra T, Echtenacher B, Roy DL, Pugin J, Metz CN, Hultner L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nat Med. 2000;6(2):164–70. Epub 2000/02/02. doi: 10.1038/7226210655104.
50. Roger T, David J, Glauser MP, Calandra T, MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature. 2001;414(6866):920–4. Epub 2002/01/10. doi: 10.1038/414920a11780066.
51. Ali MH, Schlidt SA, Chandel NS, Hynes KL, Schumacker PT, Gewertz BL, Endothelial permeability and IL-6 production during hypoxia: role of ROS in signal transduction. Am J Physiol. 1999;277(5 Pt 1):L1057–65. Epub 1999/11/24. 10564193.
52. Goldblum SE, Hennig B, Jay M, Yoneda K, McClain CJ, Tumor necrosis factor alpha-induced pulmonary vascular endothelial injury. Infect Immun. 1989;57(4):1218–26. Epub 1989/04/01. 2925247; PubMed Central PMCID: PMCPmc313253.
53. Yu H, Huang X, Ma Y, Gao M, Wang O, Gao T, et al. Interleukin-8 regulates endothelial permeability by down-regulation of tight junction but not dependent on integrins induced focal adhesions. Int J Biol Sci. 2013;9(9):966–79. Epub 2013/10/25. doi: 10.7150/ijbs.699624155670; PubMed Central PMCID: PMCPmc3805902.
54. Lee YR, Liu MT, Lei HY, Liu CC, Wu JM, Tung YC, et al. MCP-1, a highly expressed chemokine in dengue haemorrhagic fever/dengue shock syndrome patients, may cause permeability change, possibly through reduced tight junctions of vascular endothelium cells. J Gen Virol. 2006;87(Pt 12):3623–30. Epub 2006/11/14. doi: 10.1099/vir.0.82093–017098977.
55. Chen HC, Hofman FM, Kung JT, Lin YD, Wu-Hsieh BA, Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage. J Virol. 2007;81(11):5518–26. Epub 2007/03/16. doi: 10.1128/jvi.02575-0617360740; PubMed Central PMCID: PMCPmc1900309.
56. Gore Y, Starlets D, Maharshak N, Becker-Herman S, Kaneyuki U, Leng L, et al. Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J Biol Chem. 2008;283(5):2784–92. Epub 2007/12/07. doi: 10.1074/jbc.M70326520018056708.
57. Donnelly SC, Bucala R, Macrophage migration inhibitory factor: a regulator of glucocorticoid activity with a critical role in inflammatory disease. Mol Med Today. 1997;3(11):502–7. Epub 1998/02/07. doi: 10.1016/s1357-4310(97)01133-79430786.
58. Khakpoor A, Panyasrivanit M, Wikan N, Smith DR, A role for autophagolysosomes in dengue virus 3 production in HepG2 cells. J Gen Virol. 2009;90(Pt 5):1093–103. Epub 2009/03/07. doi: 10.1099/vir.0.007914–019264601.
59. Panyasrivanit M, Khakpoor A, Wikan N, Smith DR, Co-localization of constituents of the dengue virus translation and replication machinery with amphisomes. J Gen Virol. 2009;90(Pt 2):448–56. Epub 2009/01/15. doi: 10.1099/vir.0.005355–019141455.
60. Heaton NS, Randall G, Dengue virus-induced autophagy regulates lipid metabolism. Cell Host Microbe. 2010;8(5):422–32. Epub 2010/11/16. doi: 10.1016/j.chom.2010.10.00621075353; PubMed Central PMCID: PMCPmc3026642.
61. Fang YT, Wan SW, Lu YT, Yao JH, Lin CF, Hsu LJ, et al. Autophagy facilitates antibody-enhanced dengue virus infection in human pre-basophil/mast cells. PLoS One. 2014;9(10):e110655. Epub 2014/10/21. doi: 10.1371/journal.pone.011065525329914; PubMed Central PMCID: PMCPmc4199741.
62. McLean JE, Wudzinska A, Datan E, Quaglino D, Zakeri Z, Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. J Biol Chem. 2011;286(25):22147–59. Epub 2011/04/23. doi: 10.1074/jbc.M110.19250021511946; PubMed Central PMCID: PMCPmc3121359.
63. Zellweger RM, Shresta S, Mouse models to study dengue virus immunology and pathogenesis. Front Immunol. 2014;5:151. Epub 2014/05/02. doi: 10.3389/fimmu.2014.0015124782859; PubMed Central PMCID: PMCPmc3989707.
64. Zompi S, Harris E, 2012;4(1):62–82. Epub 2012/02/23. 10.3390/v4010062. 22355452; PubMed Central PMCID: PMCPmc3280519.
65. Thomas SJ, NS1: A corner piece in the dengue pathogenesis puzzle?Sci Transl Med. 2015;7(304):304fs37. doi: 10.1126/scitranslmed.aad125526355028.
66. Halstead SB, Identifying protective dengue vaccines: guide to mastering an empirical process. Vaccine. 2013;31(41):4501–7. doi: 10.1016/j.vaccine.2013.06.07923896423.
67. Chuang YC, Lin J, Lin YS, Wang S, Yeh TM, Dengue Virus Nonstructural Protein 1-Induced Antibodies Cross-React with Human Plasminogen and Enhance Its Activation. Journal of immunology. 2016;196(3):1218–26. Epub 2015/12/30. doi: 10.4049/jimmunol.150005726712948.
68. Bischoff I, Hornburger MC, Mayer BA, Beyerle A, Wegener J, Furst R, Pitfalls in assessing microvascular endothelial barrier function: impedance-based devices versus the classic macromolecular tracer assay. Sci Rep. 2016;6:23671. Epub 2016/03/31. doi: 10.1038/srep2367127025965.